A5091950160- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Advanced Breast Cancer Therapies
- Multiple Myeloma Research and Treatments
- Renal and related cancers
- Cancer Treatment and Pharmacology
- Pancreatitis Pathology and Treatment
- Glioma Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- Immune cells in cancer
- Peptidase Inhibition and Analysis
- Nanoplatforms for cancer theranostics
- Protein Degradation and Inhibitors
Baystate Health
2024-2025
University of Massachusetts Chan Medical School
2024-2025
Johns Hopkins Medicine
2023-2025
Johns Hopkins University
2023-2025
Cancer Research Center
2023-2025
Abstract Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge due to late‐stage diagnoses. To improve patient outcomes, early intervention in precursor lesions such as intraductal papillary mucinous neoplasm (IPMN) is crucial. However, must be balanced against overtreatment of low‐risk that are unlikely progress, underscoring the need better understand molecular alterations neoplastic cells and changes tumor microenvironment (TME) drive progression IPMNs. In this study, we...